Collaboration and License Agreements (Tables)

3 Months Ended

Mar. 31, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Summary of Revenue from Collaboration and License Agreements

We have recognized revenue from our collaboration and license agreements as follows (in thousands):

	Three Months Ended March 31,
	2016		2015
Daiichi Sankyo	$	3,385	$	1,128
Bayer and Janssen		3,307		799
BMS and Pfizer		1,254		380
Bayer		260		—
Lee’s Pharmaceutical		52		52
Total collaboration and license revenue	$	8,258	$	2,359